In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations.
While KRAS activation is a fundamental initiating event in the aetiopathogenesis of pancreatic ductal adenocarcinoma (PDA), environmental factors influencing the occurrence and persistence of KRAS mutations remain largely unknown. The objective was to test the hypothesis that in PDA there are aetiopathogenic relationships among concentrations of some organochlorine compounds (OCs) and the mutational status of the KRAS oncogene, as well as among the latter and coffee intake. Incident cases of PDA were interviewed and had blood drawn at hospital admission (N = 103). OCs were measured by high-resolution gas chromatography with electron capture detection. Cases whose tumours harboured a KRAS mutation had higher concentrations of p,p'-dichlorodiphenyltrichloroethane (DDT), p,p'-dichlorodiphenyldichloroethene (DDE) and polychlorinated biphenyls (PCBs) 138, 153 and 180 than cases with wild-type KRAS, but differences were statistically significant only for p,p'-DDT and PCBs 138 and 153. The association between coffee intake and KRAS mutations remained significant (P-trend < 0.015) when most OCs where accounted for. When p,p'-DDT, PCB 153, coffee and alcohol intake were included in the same model, all were associated with KRAS (P = 0.042, 0.007, 0.016 and 0.025, respectively). p,p'-DDT, p,p'-DDE and PCB 138 were significantly associated with the two most prevalent KRAS mutations (Val and Asp). OCs and coffee may have independent roles in the aetiopathogenesis of PDA through modulation of KRAS activation, acquisition or persistence, plausibly through non-genotoxic or epigenetic mechanisms. Given that KRAS mutations are the most frequent abnormality of oncogenes in human cancers, and the lifelong accumulation of OCs in humans, refutation or replication of the findings is required before any implications are assessed.
Porta
Miquel
M
Institut Municipal d'Investigació Mèdica-Hospital del Mar, E-08003 Barcelona, Catalonia, Spain. mporta@imim.es
López
Tomàs
T
Pumarega
José
J
Jariod
Manuel
M
Crous-Bou
Marta
M
Marco
Esther
E
Rifà
Juli
J
Grimalt
Joan O
JO
Malats
Núria
N
Real
Francisco X
FX
D000230:Adenocarcinoma / Q000139:chemically induced / Q000235:genetics*; D000328:Adult; D000368:Aged; D021441:Carcinoma, Pancreatic Ductal / Q000139:chemically induced / Q000235:genetics*; D016022:Case-Control Studies; D003069:Coffee; D004252:DNA Mutational Analysis; D044127:Epigenesis, Genetic; D005260:Female; D011905:Genes, ras; D006801:Humans; D006843:Hydrocarbons, Chlorinated / Q000097:blood* / Q000633:toxicity; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010190:Pancreatic Neoplasms / Q000139:chemically induced / Q000235:genetics*; D018631:ras Proteins / Q000235:genetics*
D003069:Coffee; D006843:Hydrocarbons, Chlorinated; D018631:ras Proteins